Skip to content
Stop using now Drug recall · FDA · Published November 30, 2012

West-Ward Recalls Lisinopril/HCTZ Tablets Due to Steel Particulates

West-Ward recalls specific lots of Lisinopril and Hydrochlorothiazide 20 mg/25 mg tablets due to stainless steel particulates. Check your bottle NDC and lot numbers.

🇺🇸 FDA recall #D-132-2013DrugWest-Ward Pharmaceutical ›
Take action

Contact the company

Recalling firmWest-ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

West-Ward Pharmaceutical Corp. is recalling Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg, because reports indicate the presence of minute stainless steel particulates in the pills. The affected products are packaged in 100-count and 1000-count bottles with specific National Drug Codes (NDC). The record does not state a remedy or what consumers should do with the recalled medication. Read more at govinfonow.com/recall/48472-west-ward-pharmaceutical-corp-recalls-lisinopril-and-hydrochlorothiazide-tablets-20.

Source Summary by GovInfoNow · govinfonow.com/recall/48472-west-ward-pharmaceutical-corp-recalls-lisinopril-and-hydrochlorothiazide-tablets-20 · Updated October 13, 2026 · FDA enforcement record: FDA #D-132-2013

Cite this page

“West-Ward Recalls Lisinopril/HCTZ Tablets Due to Steel Particulates.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48472-west-ward-pharmaceutical-corp-recalls-lisinopril-and-hydrochlorothiazide-tablets-20. Based on FDA recall #D-132-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-132-2013%22&limit=1).

The FDA announced on November 30, 2012, that West-Ward Pharmaceutical Corp. voluntarily recalled Lisinopril and Hydrochlorothiazide Tablets due to the presence of foreign stainless steel particulates. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: West-Ward Pharmaceutical
  • Product: Lisinopril and Hydrochlorothiazide Tablets, 20 mg/25 mg
  • NDC 0143-1264-01 (100-count bottles)
  • NDC 0143-1264-10 (1000-count bottles)
  • Lot codes: 69392A, 69393A, 69394A, 69395A, 69396A, 69397A (Exp 09/15); 69495A, 69496A, 69497A, 69498A, 69524A, 69525A (Exp 10/15)

The hazard

The recall addresses reports of gray smudges identified as minute stainless steel particulates found in the recalled tablets. The FDA stated that these foreign substances pose a potential health risk.

Context

GovInfoNow's records show West-Ward Pharmaceutical Corp. has had 23 other recalls on record since April 13, 2012. Other recent recalls of similar products include Merck Noxafil Powdermix Recall (December 12, 2025) and Sunny Pharmtech Cyclophosphamide Injection Recall (July 17, 2026).

How to tell if you have this one

Check your bottle for the National Drug Code (NDC) 0143-1264-01 or 0143-1264-10. Verify the lot numbers: 69392A, 69393A, 69394A, 69395A, 69396A, 69397A (Expiration 09/15) or 69495A, 69496A, 69497A, 69498A, 69524A, 69525A (Expiration 10/15).

  • Brand
    West-Ward Pharmaceutical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication bottle

    Verify if your Lisinopril and Hydrochlorothiazide tablets match the recalled NDCs and lot numbers listed in the record.

  2. Contact your pharmacist or doctor

    Since the remedy is not stated in the record, consult a healthcare professional for guidance on what to do with the affected medication.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 19 months after the firm started it.

1. Firm started the recall: Nov 30, 201212. FDA classified it Class II: Jan 18, 201323. Published in FDA’s Enforcement Report: Jan 30, 201334. FDA terminated the recall: Jul 9, 2014420122014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-132-2013 (November 30, 2012) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-132-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA